NCT00819169 2024-08-20QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid TumorsNantCell, Inc.Phase 1/2 Terminated89 enrolled 20 charts
NCT00625651 2014-04-25Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal CancerAmgenPhase 1/2 Completed202 enrolled
NCT00630786 2014-02-06Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyAmgenPhase 1/2 Completed53 enrolled 13 charts